Gastrointestinal Tract Complications of Nonsteroidal Anti-inflammatory Drug Treatment in Rheumatoid Arthritis
- 22 July 1996
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 156 (14), 1530-1536
- https://doi.org/10.1001/archinte.1996.00440130066007
Abstract
Background: Gastrointestinal tract (GI) complications associated with nonsteroidal anti-inflammatory drug (NSAID) use are the most common serious adverse drug reactions in the United States. Nonsteroidal antiinflammatory drugs cause both minor GI side effects such as abdominal pain and vomiting and serious GI events such as ulcers and bleeding. This study evaluates the event rates for all NSAID-induced GI complications in patients with rheumatoid arthritis, describes the time course of these events, and evaluates the role of prophylactic therapy with antacids and H2receptor antagonists. Methods: We studied 1921 patients with rheumatoid arthritis from 8 ARAMIS (Arthritis, Rheumatism, and Aging Medical Information System) centers. Patients were selected for the study if they were treated with NSAIDs and had at least 2.5 years of observation available. Information on GI complications attributed to NSAIDs was obtained from validated patient self-reports collected every 6 months and supplemented by review of hospital records for all hospitalizations. Results: Approximately 15% of the 1921 patients reported an NSAID-induced GI side effect during the 2.5-year observation period. Forty-two patients had a serious GI complication requiring hospitalization; 34 of these 42 patients did not have a preceding GI side effect. Patients who were taking antacids and H2receptor antagonists did not have a significantly lower risk for serious GI complications than did those not taking such medications. Asymptomatic patients taking these medications had a significantly higher risk for GI complications compared with those who did not take these medications (standardized odds ratio, 2.14; 95% confidence interval, 1.06-4.32). Conclusions: A large majority of patients with serious GI complications do not have preceding mild side effects. Prophylactic treatment with antacids and H2receptor antagonists is of questionable value and may increase the risk for subsequent serious GI complications. Arch Intern Med. 1996;156:1530-1536Keywords
This publication has 10 references indexed in Scilit:
- Comparative toxicity of non-steroidal anti-inflammatory agentsPharmacology & Therapeutics, 1994
- Discordance of Databases Designed for Claims Payment versus Clinical Information Systems: Implications for Outcomes ResearchAnnals of Internal Medicine, 1993
- The health assessment questionnaire 1992. Status and reviewArthritis & Rheumatism, 1992
- Comparison between Ranitidine and Omeprazole for Protection against Gastroduodenal Damage Caused by NaproxenScandinavian Journal of Gastroenterology, 1992
- Nonsteroidal Anti-inflammatory Drug Use and Increased Risk for Peptic Ulcer Disease in Elderly PersonsAnnals of Internal Medicine, 1991
- A toxicity index for comparison of side effects among different drugsArthritis & Rheumatism, 1990
- PREVENTION OF NSAID-INDUCED GASTRIC ULCER WITH MISOPROSTOL: MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALThe Lancet, 1988
- Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.BMJ, 1988
- Clinical spectrum of the upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs: Natural history, symptomatology, and significanceAmerican Journal Of Medicine, 1988
- Measurement of patient outcome in arthritisArthritis & Rheumatism, 1980